138 related articles for article (PubMed ID: 31730270)
1. Potential lung cancer screening outcomes using different age and smoking thresholds in the ANRS-CO4 French Hospital Database on HIV cohort.
Makinson A; Tron L; Grabar S; Milleron B; Reynes J; Le Moing V; Morquin D; Lert F; Costagliola D; Guiguet M
HIV Med; 2020 Mar; 21(3):180-188. PubMed ID: 31730270
[TBL] [Abstract][Full Text] [Related]
2. Invasive cervical cancer in HIV-infected women: risk and survival relative to those of the general population in France. Results from the French Hospital Database on HIV (FHDH)-Agence Nationale de Recherches sur le SIDA et les Hépatites Virales (ANRS) CO4 cohort study.
Grabar S; Hleyhel M; Belot A; Bouvier AM; Tattevin P; Pacanowski J; Genet P; Pradier C; Salmon D; Simon A; Pourcher V; Spano JP; Poizot-Martin I; Costagliola D
HIV Med; 2019 Mar; 20(3):222-229. PubMed ID: 30693646
[TBL] [Abstract][Full Text] [Related]
3. Low incidence of acute rejection within 6 months of kidney transplantation in HIV-infected recipients treated with raltegravir: the Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS) 153 TREVE trial.
Matignon M; Lelièvre JD; Lahiani A; Abbassi K; Desvaux D; Diallo A; Peraldi MN; Taburet AM; Saillard J; Delaugerre C; Costagliola D; Assoumou L; Grimbert P;
HIV Med; 2019 Mar; 20(3):202-213. PubMed ID: 30688008
[TBL] [Abstract][Full Text] [Related]
4. Psychiatric and substance use disorders in HIV/hepatitis C virus (HCV)-coinfected patients: does HCV clearance matter? [Agence Nationale de Recherche sur le SIDA et les Hépatites Virales (ANRS) HEPAVIH CO13 cohort].
Michel L; Lions C; Winnock M; Lang JP; Loko MA; Rosenthal E; Marchou B; Valantin MA; Morlat P; Roux P; Sogni P; Spire B; Poizot-Martin I; Lacombe K; Lascoux-Combe C; Duvivier C; Neau D; Dabis F; Salmon-Ceron D; Carrieri MP;
HIV Med; 2016 Nov; 17(10):758-765. PubMed ID: 27187027
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force.
Meza R; Jeon J; Toumazis I; Ten Haaf K; Cao P; Bastani M; Han SS; Blom EF; Jonas DE; Feuer EJ; Plevritis SK; de Koning HJ; Kong CY
JAMA; 2021 Mar; 325(10):988-997. PubMed ID: 33687469
[TBL] [Abstract][Full Text] [Related]
6. Levels and determinants of breast and cervical cancer screening uptake in HIV-infected women compared with the general population in France.
Tron L; Lert F; Spire B; Dray-Spira R;
HIV Med; 2017 Mar; 18(3):181-195. PubMed ID: 28967199
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.
Katki HA; Kovalchik SA; Berg CD; Cheung LC; Chaturvedi AK
JAMA; 2016 Jun; 315(21):2300-11. PubMed ID: 27179989
[TBL] [Abstract][Full Text] [Related]
8. Prediction of Lung Cancer Screening Eligibility Using Simplified Criteria.
Triplette M; Donovan LM; Crothers K; Madtes DK; Au DH
Ann Am Thorac Soc; 2019 Oct; 16(10):1280-1285. PubMed ID: 31298946
[No Abstract] [Full Text] [Related]
9. Feasibility and efficacy of early lung cancer diagnosis with chest computed tomography in HIV-infected smokers.
Makinson A; Eymard-Duvernay S; Raffi F; Abgrall S; Bommart S; Zucman D; Valour F; Cheret A; Poizot-Martin I; Duvivier C; Mauboussin JM; Bonnet F; Tattevin P; Reynes J; Le Moing V;
AIDS; 2016 Feb; 30(4):573-82. PubMed ID: 26829006
[TBL] [Abstract][Full Text] [Related]
10. Optimal Lung Cancer Screening Criteria Among Persons Living With HIV.
Sellers SA; Edmonds A; Ramirez C; Cribbs SK; Ofotokun I; Huang L; Morris A; Mccormack MC; Kunisaki KM; D'souza G; Rivera MP; Drummond MB; Adimora AA
J Acquir Immune Defic Syndr; 2022 Jun; 90(2):184-192. PubMed ID: 35125470
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Uptake Appropriateness of Computed Tomography for Lung Cancer Screening According to Patients Meeting Eligibility Criteria of the US Preventive Services Task Force.
Liu Y; Pan IE; Tak HJ; Vlahos I; Volk R; Shih YT
JAMA Netw Open; 2022 Nov; 5(11):e2243163. PubMed ID: 36409492
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Population-Level Changes Associated With the 2021 US Preventive Services Task Force Lung Cancer Screening Recommendations in Community-Based Health Care Systems.
Ritzwoller DP; Meza R; Carroll NM; Blum-Barnett E; Burnett-Hartman AN; Greenlee RT; Honda SA; Neslund-Dudas C; Rendle KA; Vachani A
JAMA Netw Open; 2021 Oct; 4(10):e2128176. PubMed ID: 34636916
[TBL] [Abstract][Full Text] [Related]
13. 5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study.
Luo YH; Luo L; Wampfler JA; Wang Y; Liu D; Chen YM; Adjei AA; Midthun DE; Yang P
Lancet Oncol; 2019 Aug; 20(8):1098-1108. PubMed ID: 31255490
[TBL] [Abstract][Full Text] [Related]
14. Increasing burden of noninfectious lung disease in persons living with HIV: a 7-year study using the French nationwide hospital administrative database.
Maitre T; Cottenet J; Beltramo G; Georges M; Blot M; Piroth L; Bonniaud P; Quantin C
Eur Respir J; 2018 Sep; 52(3):. PubMed ID: 30139778
[TBL] [Abstract][Full Text] [Related]
15. How does loss to follow-up influence cohort findings on HIV infection? A joint analysis of the French hospital database on HIV, Mortalité 2000 survey and death certificates.
Lanoy E; Lewden C; Lièvre L; Tattevin P; Boileau J; Aouba A; Chêne G; Costagliola D; ;
HIV Med; 2009 Apr; 10(4):236-45. PubMed ID: 19178591
[TBL] [Abstract][Full Text] [Related]
16. Benefits of task-shifting HIV care to nurses in terms of health-related quality of life in patients initiating antiretroviral therapy in rural district hospitals in Cameroon [Stratall Agence Nationale de Recherche sur le SIDA (ANRS) 12110/Ensemble pour une Solidarité Thérapeutique Hospitalière en Réseau (ESTHER) substudy].
Suzan-Monti M; Blanche J; Boyer S; Kouanfack C; Delaporte E; Bonono RC; Carrieri PM; Protopopescu C; Laurent C; Spire B;
HIV Med; 2015 May; 16(5):307-18. PubMed ID: 25721267
[TBL] [Abstract][Full Text] [Related]
17. Disparities of National Lung Cancer Screening Guidelines in the US Population.
Han SS; Chow E; Ten Haaf K; Toumazis I; Cao P; Bastani M; Tammemagi M; Jeon J; Feuer EJ; Meza R; Plevritis SK
J Natl Cancer Inst; 2020 Nov; 112(11):1136-1142. PubMed ID: 32040195
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of and factors associated with depression among people living with HIV in France.
Feuillet P; Lert F; Tron L; Aubriere C; Spire B; Dray-Spira R;
HIV Med; 2017 Jul; 18(6):383-394. PubMed ID: 27625202
[TBL] [Abstract][Full Text] [Related]
19. Prospective CT screening for lung cancer in a high-risk population: HIV-positive smokers.
Hulbert A; Hooker CM; Keruly JC; Brown T; Horton K; Fishman E; Rodgers K; Lee B; Sam C; Tsai S; Weihe E; Pridham G; Drummond B; Merlo C; Geronimo M; Porter M; Cox S; Li D; Harline M; Teran M; Wrangle J; Mudge B; Taylor G; Kirk GD; Herman JG; Moore RD; Brown RH; Brock MV
J Thorac Oncol; 2014 Jun; 9(6):752-9. PubMed ID: 24828660
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
